Biib Analyst Sees No Clear Growth Driver to Replace Alzheimer’s Drug

Date: 2019-03-21 14:39:12

[dn_wp_yt_youtube_source type=”101″ id=”pWt-uiQCyxc”]

Mar.21 — Matteis, Manageress Directorship of Biotechnology equity research at Stifel, discusses Inc. halting research on its Experimental Alzheimer’s drug. He Speech on “Bloomberg Daybreak: Americas.”